Posted on 8/15/18
Charles River Laboratories (CRL) Investor Presentation - Slideshow
The following slide deck was published by Charles River Laboratories International, Inc. in conjunction with this event. 1108READ FULL ARTICLE HERE
Posted on 8/15/18
Better Buy: GlaxoSmithKline plc vs. Bristol-Myers Squibb
You would have been better off not owning either GlaxoSmithKline plc (NYSE:GSK) or Bristol-Myers Squibb (NYSE:BMY) over the last few years. GlaxoSmithKline's share price fell during . . .
Posted on 8/15/18
Mersana Therapeutics Provides Business Updates
CAMBRIDGE, Mass., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug . . .
Posted on 8/14/18
U.S. News & World Report Names Hartford Hospital Best in Region
Hartford Hospital has been ranked #1 in the Hartfordregion and among the best in Connecticut for 2017-2018 by U.S. News & World Report. The annual U.S. . . .
Posted on 8/14/18
scPharmaceuticals Reports Q2 2018 Financial Results and Provides Business Update
BURLINGTON, Mass., Aug. 14, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to . . .
Posted on 8/14/18
Elligo Health Research Partners with Women's Health USA
AUSTIN, Texas & AVON, Conn.--(BUSINESS WIRE)--Elligo Health Research, which offers the only platform that brings clinical research direct to clinical health care, announces its partnership with . . .
Posted on 8/14/18
Lumeon’s Care Pathway Management Platform Rapidly Gaining Industry Recognition
BOSTON--(BUSINESS WIRE)--Lumeon, the leader in Care Pathway Management (CPM), today announced that its Care Pathway Management (CPM) platform has earned two prestigious industry recognitions. In the . . .
Posted on 8/14/18
Biostage Reports 2018 Second Quarter Financial Results
Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, today announced its financial results . . .
Posted on 8/14/18
ReWalk Robotics Reports Second Quarter 2018 Financial Results
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., Aug. 14, 2018 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) today announced its financial results for the three- and . . .
Posted on 8/14/18
Why Berkshire May Be Buying Back Stock Right Now
On July 17, Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) announced a change to its share repurchase program: "The earlier share repurchase program provided that the price paid for . . .
Posted on 8/13/18
Acer Therapeutics Provides Corporate Update
NEWTON, Mass., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for . . .
Posted on 8/13/18
Unum Therapeutics Provides Business Update
CAMBRIDGE, Mass., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies based on . . .
Posted on 8/13/18
Arsanis Reports Financial Results for Second Quarter 2018
WALTHAM, Mass. and VIENNA, Austria, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Arsanis, Inc. (NASDAQ: ASNS), a clinical-stage biopharmaceutical company focused on applying monoclonal antibody (mAb) immunotherapies . . .
Posted on 8/13/18
3 Beaten-Down Biotech Stocks: Can They Recover?
It's been an outstanding year for fledgling biotechnology companies across the board, but these three haven't fared as well as the rest of their industry in . . .
Posted on 8/13/18
Berkshire Hathaway’s Business: An Overview
Many investors know Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) as "Warren Buffett's company," but they aren't sure exactly how it makes money. And the answer is a bit . . .
Posted on 8/13/18
Berkshire Hathaway’s Massive Cash Hoard
In Berkshire Hathaway's (NYSE:BRK-A) (NYSE:BRK-B) second-quarter earnings report, we learned that the conglomerate's stockpile of cash has grown to more than $111 billion. Here's why the . . .
Posted on 8/13/18
Berkshire Hathaway’s New Buyback Plan -- Here’s What Investors Need to Know
Berkshire Hathaway's (NYSE:BRK-A) (NYSE:BRK-B) board just decided to give CEO Warren Buffett and Vice Chairman Charlie Munger quite a bit more freedom when it comes to . . .
Posted on 8/13/18
Why Biogen's Stock Ripped Higher in July
What happened Shares of large-cap biotech Biogen (NASDAQ:BIIB) gained a healthy 15.2% in July, according to data from S&P Global Market Intelligence. What triggered this breakout? . . .
Posted on 8/10/18
Solid Biosciences Reports Second Quarter 2018 Financial Results and Provides Business Update
CAMBRIDGE, Mass., Aug. 10, 2018 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ:SLDB) today reported financial results for the second quarter ended June 30, 2018 and provided . . .
Posted on 8/10/18
Berkshire Hathaway’s Earnings and Massive Cash Hoard
Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) recently released its second-quarter results, and the business is doing quite well. Insurance revenue was up significantly and the company ran a . . .
Posted on 8/10/18
OvaScience Provides Strategic Alternatives Update
WALTHAM, Mass.--(BUSINESS WIRE)--OvaScienceSM (Nasdaq:OVAS), a company focused on developing novel treatments for women and couples struggling with infertility, today reported financial results for the second quarter . . .
Posted on 8/10/18
Peak Physical Therapy & Sports Performance Celebrates 10th Anniversary
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide comprehensive treatment in orthopedic, spine and sports medicine specialties, is . . .
Posted on 8/10/18
Scholar Rock Updates on Business Progress
CAMBRIDGE, Mass., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Scholar Rock (NASDAQ:SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth . . .
Posted on 8/10/18
Spring Bank Prices Public Offering of Common Stock
HOPKINTON, Mass. and NEW YORK, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) today announced the pricing of an underwritten public offering . . .
Posted on 8/10/18
AVROBIO Provides Business Update
CAMBRIDGE, Mass., Aug. 09, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc. (NASDAQ:AVRO), a Phase 2 clinical stage gene therapy company focused on developing potentially curative lentiviral-based gene . . .

